Methyl 2-oxo-2,3-dihydrobenzo[d]thiazole-6-carboxylate, 98%, 250mg

3-Acetyl-5-chlorothiophene-2-sulfonamide, 95.0%, 100g

4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole, 95.0%, 5g

Thalidomide-O-PEG4-azide, 250mg

2-[3,5-Bis(1-Phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole, 97%, 100mg

1-[1-(Bromomethyl)cyclopropyl]methanamine hydrobromide, 98%, 500mg

2-(4-(BENZYLOXY)PHENYL)-3-METHYLBUTANOIC ACID, 95.0%, 250mg

(R)-3-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 1g

Fil de platine, minimum 99,95 %, diamètre 0,5 mm, 25 cm, gainé de plastique.

4-Methyl-2-oxovaleric Acid>95.0%(GC)(T)5g

5-Chloro-1H-indazole-3-carbaldehyde, 95.0%, 250mg

2-(1-methyl-1H-pyrazol-3-yl)acetic acid hydrochloride, 95.0%, 1g

2-(Quinolin-2-yl)-4,5-dihydrooxazole, 98.0%, 1g